Skip to main content
. 2020 Apr 28;13:1756286420918088. doi: 10.1177/1756286420918088

Figure 2.

Figure 2.

Meta-analysis forest plots. (A) Meta-analysis of mean difference of change in monthly migraine days of galcanezumab 120 mg versus placebo and (B) meta-analysis of mean difference of change in monthly migraine days of galcanezumab 240 mg versus placebo.

(A) Change in monthly migraine days – mean difference of galcanezumab 120 mg versus placebo.

(B) Change in monthly migraine days – mean difference of galcanezumab 240 mg versus placebo.